文献速递脊柱关节炎其他结缔组织病

银屑病关节炎中的维生素D——系统综述与荟萃分析

Vitamin D in psoriatic arthritis - A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2023-04-01

该系统综述与荟萃分析检索了截至2022年10月12日的四个数据库,纳入队列、随机对照试验或观察性研究,评估银屑病关节炎(PsA)患者的25(OH)D3水平。结果显示,PsA患者的维生素D水平低于健康对照组(MD=−6.42;95%CI −8.31,−4.53;P<0.01),但高于银屑病(Pso)患者(MD=2.37;95%CI 0.97,3.78;P<0.01)。纳入研究偏倚风险为中至低。

要点

  • 与健康对照组相比,PsA患者维生素D水平更低(MD=−6.42;95%CI −8.31,−4.53;P<0.01)。
  • 与银屑病患者相比,PsA患者维生素D水平更高(MD=2.37;95%CI 0.97,3.78;P<0.01)。
  • 纳入研究偏倚风险为中至低,但作者认为需进一步研究以理解维生素D在PsA发生和治疗中的作用。

核心结论

  • PsA患者的维生素D水平低于一般人群,但作者认为需进一步研究以理解维生素D在PsA发生和治疗中的作用以及PsA与Pso维生素D代谢的差异。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Web of Science、Scopus和Cochrane Library数据库,检索日期为2022年10月12日。
  • 纳入队列、随机对照试验或观察性研究,评估25(OH)D3水平,对照组为健康人或银屑病患者,采用Nottingham-Ottawa质量量表评估方法学质量。
  • 采用随机效应荟萃分析模型,以逆方差加权计算均数差及95%CI。
  • 4项研究纳入264例PsA患者和287例健康对照,5项研究纳入225例PsA患者和391例Pso患者评估维生素D水平。

主要发现

  • PsA患者维生素D水平低于健康对照组(MD=−6.42;95%CI −8.31,−4.53;P<0.01)。
  • PsA患者维生素D水平高于Pso患者(MD=2.37;95%CI 0.97,3.78;P<0.01)。
  • 纳入研究偏倚风险为中至低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需进一步研究以理解维生素D在PsA发生和治疗中的作用以及PsA与Pso维生素D代谢的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This systematic review and meta-analysis aimed to summarize current evidence on vitamin D status in patients with psoriatic arthritis (PsA) with a particular focus on disease activity. METHODS: PubMed, Web of Science, Scopus and Cochrane Library databases were searched for studies that investigated vitamin D levels in PsA. The search was conducted on 12th October 2022. Included studies were cohorts, RCTs or observational studies, those assessing the level of 25(OH)D3 with control group consisting of healthy or psoriasis (Pso) patients. Nottingham-Ottawa Quality Scale was used to assess methodological quality. Random effects meta-analysis model was applied with inverse variance weighting and mean difference with 95% CI was calculated. RESULTS: Of 356 retrieved studies, 76 duplicates and 270 studies were excluded according to the exclusion criteria with one study unavailable. Four studies including 264 PsA patients and 287 healthy controls and five studies including 225 PsA patients and 391 Pso patients assessing vitamin D levels were eligible for meta-analysis. Vitamin D levels were lower in PsA patients compared to the healthy group (MD = -6.42; 95 % CI -8.31, -4.53; P < 0.01), while higher compared to Pso patients (MD = 2.37; 95 % CI 0.97, 3.78; P < 0.01). Included studies had moderate to low risk of bias. CONCLUSION: In conclusion, PsA patients have lower vitamin D levels than the general population. However, further studies are essential to understand the role of vitamin D in the development and treatment of PsA and the differences in vitamin D metabolism in PsA and Pso.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Radić M, Đogaš H, Kolak E, et al. Vitamin D in psoriatic arthritis - A systematic review and meta-analysis. Semin Arthritis Rheum. 2023. PMID: 37062151. doi:10.1016/j.semarthrit.2023.152200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。